SCHEMBL29926382

SCHEMBL29926382

CC(C)(C)OC(=O)c1cc2cc(B3OC(C)(C)C(C)(C)O3)ccc2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
AAK1 Q2M2I8 2/20 0.40
BACE1 P56817 1/20 0.39
BACE2 Q9Y5Z0 1/20 0.39
F11 P03951 3/20 0.38
F2 P00734 2/20 0.38
PRSS1 P07477 2/20 0.38
PRSS2 P07478 2/20 0.38
PRSS3 P35030 2/20 0.38
PIM1 P11309 1/20 0.37
HIF1A Q16665 2/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
DGAT1 O75907 1/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23810607 1.00 PRMT5 (0.41) PRMT5WDR77AAK1BACE1BACE2
SCHEMBL17206037 0.86 HIF1A (0.41) F11F2PRSS1PRSS2PRSS3
SCHEMBL23321023 0.84 BACE1 (0.31) PRMT5WDR77AAK1BACE1BACE2
SCHEMBL6225537 0.83 MAOB (0.44) CA2CA9KDM4EALDH1A1HPGD
SCHEMBL28339887 0.82 PIM1 (0.51) F11F2PRSS1PRSS2PRSS3
SCHEMBL28507918 0.79 AAK1 (0.43) PRMT5WDR77AAK1BACE1BACE2
SCHEMBL24943919 0.78 TAS1R3 (0.49) LMNAALDH1A1
SCHEMBL19079911 0.78 PRMT5 (0.55) PRMT5WDR77AAK1BACE1BACE2
SCHEMBL2960924 0.77 NPC1 (0.56) ALDH1A1HPGDSMN1; SMN2FLT3
SCHEMBL3487931 0.76 FLT3 (0.61) F2PIM1CA2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115087658-A Sulfonamide or sulfenamide compounds having BRD 4-inducing proteolytic activity, and pharmaceutical use thereof 田边三菱制药株式会社 2022-09-20 CN disclosed